Fingerprint
Dive into the research topics of 'Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Research output: Contribution to journal › Article › peer-review